Request Information
Clinical Lymphoma, Myeloma & Leukemia
- Editors:
- Jagannath, Sundar, MD
- Publisher:
- Elsevier
- 2023 Journal Impact Factor:
- 2.7 (Journal Citation Report, Web of Science Group)
- ISSN:
- 2152-2650
-
Description
-
Details
Description
A peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma and myeloma.
This unique, focused journal is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, and related disorders - including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma and myeloma. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
This unique, focused journal is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, and related disorders - including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma and myeloma. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
Details
- Platform:
- OvidSP
- Publisher:
- Elsevier
- Product Type:
- Journal
- Author:
- Jagannath, Sundar, MD
- ISSN:
- 2152-2650
- Specialty:
-
- Internal Medicine
- Oncology
- Language:
- English
- Update Frequency:
- Monthly
- Coverage:
- Vol 10 #1 (2010) - Present
- Pdf Coverage:
- Vol 10 #1 (2010) - Present
- 2023 Journal Impact Factor:
- 2.7 (Journal Citation Report, Web of Science Group)